A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
In brief
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.
Key facts
- Study ID
- NCT06318169
- Run by
- 89bio, Inc.
- People needed
- 1350
- Starts
- 2024-03-13
- Expected to finish
- 2029-02-01
- Last updated by the study team
- 2026-08-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- 89bio Clinical Study Site — Poway, California, United States (enrolling)
- 89bio Clinical Study Site — Rialto, California, United States (enrolling)
- 89bio Clinical Study Site — Pasadena, California, United States (enrolling)
- 89bio Clinical Study Site — Sun City, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Birmingham, Alabama, United States (enrolling)
- 89bio Clinical Study Site — Tucson, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Chandler, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Little Rock, Arkansas, United States (enrolling)
- 89bio Clinical Study Site — North Little Rock, Arkansas, United States (enrolling)
- 89bio Clinical Study Site — Canoga Park, California, United States (enrolling)
- 89bio Clinical Study Site — Tucson, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Escondido, California, United States (enrolling)
- 89bio Clinical Study Site — Fountain Valley, California, United States (enrolling)
- 89bio Clinical Study Site — Fresno, California, United States (enrolling)
- 89bio Clinical Study Site — Gardena, California, United States (enrolling)
- 89bio Clinical Study Site — Glendale, Arizona, United States (enrolling)
- 89bio Clinical Study Site — Inglewood, California, United States (enrolling)
- 89bio Clinical Study Site — La Jolla, California, United States (enrolling)
- 89bio Clinical Study Site — Lancaster, California, United States (enrolling)
- 89bio Clinical Study Site — Long Beach, California, United States (enrolling)
- 89bio Clinical Study Site — Los Angeles, California, United States (enrolling)
- 89bio Clinical Study Site — Montclair, California, United States (enrolling)
- 89bio Clinical Study Site — Orange, California, United States (enrolling)
- 89bio Clinical Study Site — Coronado, California, United States (enrolling)
- 89bio Clinical Study Site — Stanford, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.